Free Trial Information
BioCentury | Jan 22, 2021
Management Tracks

Woodman to guide Eisai’s cancer unit; plus Mengyu Lu joins Kirkland & Ellis in Hong Kong, and Splice Bio, Tarsus, Verastem, Fulcrum and more

...the Hong Kong office. Barcelona-based Splice Bio named Jean-Philippe Combal chairman. Backed by Ysios Capital, Asabys Partners...
Read More
BioCentury | Oct 31, 2020
Deals

Oct. 30 Quick Takes: Q32 raises B round; plus CStone-LegoChem, Centrexion, Sidekick

...therapeutics company, has raised $20 million in a series A round led by Wellington Partners and Asabys Partners...
Read More
BioCentury | Jun 16, 2020
Finance

Barcelona’s Ona takes aim at metastasis with €30M series A

...targeting a lipid metabolism pathway whose inhibition has been associated with prevention of metastasis. Barcelona-based Asabys Partners...
Read More
Items per page:
1 - 3 of 3
BioCentury | Jan 22, 2021
Management Tracks

Woodman to guide Eisai’s cancer unit; plus Mengyu Lu joins Kirkland & Ellis in Hong Kong, and Splice Bio, Tarsus, Verastem, Fulcrum and more

...the Hong Kong office. Barcelona-based Splice Bio named Jean-Philippe Combal chairman. Backed by Ysios Capital, Asabys Partners...
Read More
BioCentury | Oct 31, 2020
Deals

Oct. 30 Quick Takes: Q32 raises B round; plus CStone-LegoChem, Centrexion, Sidekick

...therapeutics company, has raised $20 million in a series A round led by Wellington Partners and Asabys Partners...
Read More
BioCentury | Jun 16, 2020
Finance

Barcelona’s Ona takes aim at metastasis with €30M series A

...targeting a lipid metabolism pathway whose inhibition has been associated with prevention of metastasis. Barcelona-based Asabys Partners...
Read More
Items per page:
1 - 3 of 3